Drug intelligence / Profile preview

doconexent + icosapent + lycopene + selenium + ubidecarenone

Development stage
Unknown
Lead developer
Wahl
Modality
Small Molecules
Administration
Oral
01

Overview

Wahlrise is a multi-ingredient nutritional supplement marketed by Beste Wahl India. It is formulated as a softgel capsule containing a combination of coenzyme Q10 (ubidecarenone), omega-3 fatty acids (specifically eicosapentaenoic acid [icosapent] and docosahexaenoic acid [doconexent]), lycopene, and selenium. This combination is designed to support cardiovascular health, enhance cellular energy production, boost immune function, and provide potent antioxidant protection against oxidative stress. It is commonly used to address nutritional deficiencies and support overall physiological well-being.

Brand names
Wahlrise
Other names
CoQ10/Omega-3/Lycopene/Selenium softgelcoenzyme Q10 + docosahexaenoic acid + eicosapentaenoic acid + lycopene + seleniumcoenzyme Q10, omega-3, lycopene, seleniumwahrise
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)NADH:ubiquinone oxidoreductase subunit familySDHA (Succinate dehydrogenase flavoprotein subunit)

Beyond the preview

Go deeper on doconexent + icosapent + lycopene + selenium + ubidecarenone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on doconexent + icosapent + lycopene + selenium + ubidecarenone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call